Nemaura Medical Inc.

DB:N18A 株式レポート

時価総額:€2.4m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Nemaura Medical 将来の成長

Future 基準チェック /26

Nemaura Medical's earnings are forecast to decline at 20.8% per annum while its annual revenue is expected to grow at 214.5% per year. EPS is expected to decline by 19.1% per annum.

主要情報

-20.8%

収益成長率

-19.1%

EPS成長率

Medical Equipment 収益成長15.7%
収益成長率214.5%
将来の株主資本利益率n/a
アナリストカバレッジ

Low

最終更新日22 Feb 2024

今後の成長に関する最新情報

更新なし

Recent updates

業績と収益の成長予測

DB:N18A - アナリストの将来予測と過去の財務データ ( )USD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
3/31/20251-13N/A-111
3/31/20240-9N/A-71
12/31/2023N/A-11-10-10N/A
9/30/20230-10-10-10N/A
6/30/20230-13-9-9N/A
3/31/20230-14-9-8N/A
12/31/20220-13-9-8N/A
9/30/20221-15-8-8N/A
6/30/20221-14-8-7N/A
3/31/20221-14-7-7N/A
12/31/20210-12-7-6N/A
9/30/2021N/A-10-8-6N/A
6/30/2021N/A-9-8-7N/A
3/31/2021N/A-6-7-6N/A
12/31/2020N/A-5-6-6N/A
9/30/2020N/A-4-5-5N/A
6/30/2020N/A-4-4-4N/A
3/31/2020N/A-4-4-3N/A
12/31/2019N/A-4-4-4N/A
9/30/2019N/A-5-4-4N/A
6/30/2019N/A-5-4-4N/A
3/31/2019N/A-4-4-4N/A
12/31/2018N/A-3-3-3N/A
9/30/2018N/A-3-3-3N/A
6/30/2018N/A-2-2-2N/A
3/31/2018N/A-2-2-2N/A
12/31/2017N/A-2-2-2N/A
9/30/2017N/A-2N/A-2N/A
6/30/2017N/A-1N/A-1N/A
3/31/2017N/A-2N/A-1N/A
12/31/2016N/A-2N/A-1N/A
9/30/2016N/A-2N/A-1N/A
6/30/2016N/A-2N/A-1N/A
3/31/2016N/A-2N/A-1N/A
12/31/2015N/A-2N/A-1N/A
9/30/2015N/A-1N/A-1N/A
6/30/2015N/A-1N/A-1N/A
3/31/2015N/A-1N/A-1N/A
12/31/2014N/A-1N/A0N/A
9/30/2014N/A-1N/A1N/A
6/30/2014N/A-1N/A1N/A
3/31/2014N/A-1N/A2N/A

アナリストによる今後の成長予測

収入対貯蓄率: N18A is forecast to remain unprofitable over the next 3 years.

収益対市場: N18A is forecast to remain unprofitable over the next 3 years.

高成長収益: N18A is forecast to remain unprofitable over the next 3 years.

収益対市場: N18A's revenue (214.5% per year) is forecast to grow faster than the German market (5.5% per year).

高い収益成長: N18A's revenue (214.5% per year) is forecast to grow faster than 20% per year.


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: Insufficient data to determine if N18A's Return on Equity is forecast to be high in 3 years time


成長企業の発掘